CRNC 📈 Cerence - Overview
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US1567271093
CRNC: Virtual Assistants, Speech Recognition, Artificial Intelligence, Software Components
Cerence Inc. provides AI powered virtual assistants for the mobility/transportation market in United States, Other Americas, Germany, Europe, Middle East, Africa, Japan, and Other Asia-Pacific. The company offers edge software components, cloud-connected components, virtual assistant coexistence, and professional services. It also provides conversational artificial intelligence-based solutions, including speech recognition, natural language understanding, speech signal enhancement, text-to-speech, and acoustic modeling technology. Cerence Inc. is headquartered in Burlington, Massachusetts. Web URL: https://www.cerence.com
Additional Sources for CRNC Stock
News:
Wall Street Journal
Benzinga
Yahoo Finance
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
CRNC Stock Overview
| Market Cap in USD | 356m |
| Sector | Technology |
| Industry | Software - Application |
| GiC Sub-Industry | Systems Software |
| IPO / Inception | 2019-10-02 |
CRNC Stock Ratings
| Growth 5y | -74.9% |
| Fundamental | -15.9% |
| Dividend | - |
| Rel. Strength Industry | -336 |
| Analysts | 3.25/5 |
| Fair Price Momentum | 6.92 USD |
| Fair Price DCF | 7.12 USD |
CRNC Dividends
No Dividends PaidCRNC Growth Ratios
| Growth Correlation 3m | 77.7% |
| Growth Correlation 12m | -65% |
| Growth Correlation 5y | -70.1% |
| CAGR 5y | -18.60% |
| CAGR/Mean DD 5y | -0.32 |
| Sharpe Ratio 12m | -0.01 |
| Alpha | -99.47 |
| Beta | 1.70 |
| Volatility | 134.72% |
| Current Volume | 1226.3k |
| Average Volume 20d | 2116.9k |
What is the price of CRNC stocks?
As of January 02, 2025, the stock is trading at USD 7.85 with a total of 1,226,338 shares traded.
Over the past week, the price has changed by -9.98%, over one month by +2.35%, over three months by +164.31% and over the past year by -58.88%.
As of January 02, 2025, the stock is trading at USD 7.85 with a total of 1,226,338 shares traded.
Over the past week, the price has changed by -9.98%, over one month by +2.35%, over three months by +164.31% and over the past year by -58.88%.
Is Cerence a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Cerence is currently (January 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -15.91 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CRNC as of January 2025 is 6.92. This means that CRNC is currently overvalued and has a potential downside of -11.85%.
Neither. Based on ValueRay Fundamental Analyses, Cerence is currently (January 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -15.91 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CRNC as of January 2025 is 6.92. This means that CRNC is currently overvalued and has a potential downside of -11.85%.
Is CRNC a buy, sell or hold?
Cerence has received a consensus analysts rating of 3.25. Therefor, it is recommend to hold CRNC.
Cerence has received a consensus analysts rating of 3.25. Therefor, it is recommend to hold CRNC.
- Strong Buy: 1
- Buy: 0
- Hold: 7
- Sell: 0
- Strong Sell: 0
What are the forecast for CRNC stock price target?
According to ValueRays Forecast Model, CRNC Cerence will be worth about 7.6 in January 2026. The stock is currently trading at 7.85. This means that the stock has a potential downside of -3.31%.
According to ValueRays Forecast Model, CRNC Cerence will be worth about 7.6 in January 2026. The stock is currently trading at 7.85. This means that the stock has a potential downside of -3.31%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | 7 | -10.8% |
| Analysts Target Price | 31.5 | 301.3% |
| ValueRay Target Price | 7.6 | -3.3% |